Teva’s Allergan acquisition goes ahead
Part of UK business to be sold.
X
Teva’s Allergan acquisition goes ahead
https://pharmaphorum.com/news/tevas-allergan-acquisition-goes-ahead/
Teva
Teva’s $40 billion Allergan deal cleared
Acquisition of generics business set for next week.
$40bn Teva generic deal awaits antitrust approval
Acquisition of Allergan’s generics business ready.
Impax buys Teva and Allergan generics for $586 million
Teva must sell some assets before buying Allergan’s generics business.
Teva walks away from Mesoblast’s heart failure drug
Mesoblast to continue developing stem cell based therapy.